Competitive ELISA for detection of native <i>ras</i> gene‐related products in sera of cancer patients
Ron Epelbaum(University of Bern), Channa Shalitin(Technion – Israel Institute of Technology), N. Tugendhaft(Technion – Israel Institute of Technology), Mila Rivkin(Hadassah Medical Center), Arie H. Bartal(Technion – Israel Institute of Technology)
Cited by 9
Related Papers
Curcumin as an Anti-Cancer Agent: Review of the Gap Between Basic and Clinical Applications
|Current Medicinal Chemistry|2009|480
Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers
|British Journal of Cancer|2014|444
<sup>18</sup>F-FDG Avidity in Lymphoma Readdressed: A Study of 766 Patients
|Journal of Nuclear Medicine|2009|381
Curcumin and Gemcitabine in Patients With Advanced Pancreatic Cancer
|Nutrition and Cancer|2010|279